Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Donald R Nixon, Nicholas Flinn & Claudia Enderlein. (2021) Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept. Clinical Ophthalmology 15, pages 4439-4445.
Read now
Read now
Donald R Nixon & Nicholas Flinn. (2021) Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor. Clinical Ophthalmology 15, pages 1659-1666.
Read now
Read now
Articles from other publishers (10)
Sebastian Dieke, Stefanie Wurche, Anne Ruebsam, Christopher Wirbelauer, Antonia M. Joussen & Sibylle Winterhalter. (2023) Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME. Graefe's Archive for Clinical and Experimental Ophthalmology 261:7, pages 1823-1833.
Crossref
Crossref
Grace Baldwin, Filippos Vingopoulos, Rebecca Zeng, Hannah Wescott, Augustine Bannerman, Thomas Koch, Kira Wang, Itika Garg, Raviv Katz, Leo A. Kim & John B. Miller. (2023) Association Between Contrast Sensitivity and Central Subfield Thickness in Center-Involving Diabetic Macular Edema. Journal of VitreoRetinal Diseases 7:3, pages 232-238.
Crossref
Crossref
Anastasios E. Sepetis, Holly Clarke & Bhaskar Gupta. (2022) Functional and structural characteristics in patients with diabetic macular oedema after switching from ranibizumab to aflibercept treatment. Three year results in real world settings. International Journal of Retina and Vitreous 8:1.
Crossref
Crossref
Kian Madjedi, Austin Pereira, Brian G. Ballios, Parnian Arjmand, Peter J. Kertes, Michael Brent & Peng Yan. (2022) Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review. Survey of Ophthalmology 67:5, pages 1364-1372.
Crossref
Crossref
A. Couturier, A. Giocanti-Auregan & P. Massin. (2020) Les switchs de traitement dans l’œdème maculaire diabétique : revue de la littérature et algorithme de prise en charge. Journal Français d'Ophtalmologie 43:8, pages 710-717.
Crossref
Crossref
Juha‐Matti Lindholm, Claudia Taipale, Petteri Ylinen & Raimo Tuuminen. (2019) Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. Acta Ophthalmologica 98:1, pages 36-42.
Crossref
Crossref
Sergio E. Hernández Da Mota, Francisco Béjar Cornejo, Marcela Esquivel Velázquez, Virgilio Lima Gómez, Gerardo González Saldívar, Ernesto Rodríguez Ayala & Raul Vélez-Montoya. (2020) Autofluorescence indexes as biomarkers for antiangiogenic loading dose outcome in diabetic macular edema. Therapeutic Advances in Ophthalmology 12, pages 251584142094266.
Crossref
Crossref
Raimo Tuuminen & Andrzej Grzybowski. (2019) LogMAR gain: Insufficient parameter to conclude HbA1c levels do not affect cataract surgery outcomes. Journal of Cataract and Refractive Surgery 45:8, pages 1211-1212.
Crossref
Crossref
Abeer M. Khattab, Sherein M. Hagras, AhmedHosni AbdElhamid, Magda A. Torky, Eman A. Awad & Ameera G. Abdelhameed. (2019) Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology 257:7, pages 1373-1380.
Crossref
Crossref
Badr O. Alahmadi, Amro A. Omari, Maria Fernanda Abalem, Chris Andrews, Dana Schlegel, Kari H. Branham, Naheed W. Khan, Abigail Fahim & Thiran Jayasundera. (2018) Contrast sensitivity deficits in patients with mutation-proven inherited retinal degenerations. BMC Ophthalmology 18:1.
Crossref
Crossref